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Abstract Sphingosylphosphorylcholine (SPC), a sphingolipid,
concentration-dependently (1^50 WM) induced contraction and
slight elevation of the cytosolic Ca2+ concentration ([Ca2+]i) in
smooth muscle of the pig coronary artery, the result being a
marked increase in the force/[Ca2+]i ratio. In K-toxin- or L-escin-
permeabilized, but not Triton X-100-permeabilized, vascular
strips, SPC induced contraction at constant [Ca2+]i (pCa 6.3) in
the absence of GTP, whereas a G-protein-coupled receptor
agonist, histamine, required the presence of GTP to induce the
contraction. The Rho-kinase blocker, Y-27632 (10 WM) abol-
ished the SPC-induced Ca2+-sensitization, without affecting the
Ca2+-induced contraction. These results suggest that SPC
induces Ca2+-sensitization of force in vascular smooth muscle,
presumably through the activation of Rho-kinase (or a related
kinase). ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Sphingolipids are novel messengers for signal transduction
in various cellular processes, including apoptosis and cell pro-
liferation [1^3]. One of the sphingolipids, sphingosylphosphor-
ylcholine (SPC) is generated by N-deacylation of sphingomye-
lin, which is one of the most abundant lipids in the cell
membrane. In various cultured cells, SPC directly induces
an increase of cytosolic Ca2 concentration ([Ca2]i) [2,3],
which might lead to cellular responses through Ca2-depen-
dent enzymes. We recently found that SPC induces [Ca2]i
elevation and NO production in endothelial cells in situ [4].
In smooth muscle cells, the contraction is primarily regulated
by [Ca2]i via Ca2-calmodulin-dependent myosin light chain
kinase (MLCK). SPC was reported to decrease the length of
smooth muscle cells isolated from the rectosigmoid of the
rabbit [5]. These reports raised the possibility that SPC could
induce the contraction of vascular smooth muscle. However,
the e¡ect of SPC on the contractile regulation of vascular
smooth muscle is not well understood. In addition to the
[Ca2]i-dependent mechanism in smooth muscle, the modula-
tion of Ca2 sensitivity of the contractile apparatus was re-
cently found to be the mechanism that can [Ca2]i-indepen-
dently regulate smooth muscle contraction [6,7]. We showed
that Rho-kinase directly induces contraction through an in-
crease in the phosphorylation of the myosin light chain, in-
dependent of the Ca2-calmodulin-dependent MLCK path-
way [7,8]. A recent report shows that the Ca2-sensitization
mediated by Rho-kinase contributes to blood pressure regu-
lation in vivo and may participate in hypertension [9]. How-
ever, the activation mechanism of Rho-kinase mediation of
the Ca2-sensitization remains to be determined [7], except
for the possibility that RhoA [10^12] and arachidonic acid
[13,14] may be involved in activation of this pathway. There-
fore, increasing interest has been directed toward mechanisms
involved in Ca2-sensitization in vascular smooth muscle.
In this study, using simultaneous measurement of [Ca2]i
and force, and membrane permeabilization techniques, we
demonstrate for the ¢rst time that SPC potentiates the Ca2
sensitivity of the contractile apparatus in vascular smooth
muscle, an activity abolished by the Rho-kinase inhibitor
(Y-27632) [9] and observed even in the absence of GTP, which
is required for activation of the receptor-coupled G-proteins.
Our results are compatible with the notion that SPC may be a
novel mediator for the Ca2-sensitization of vascular smooth
muscle contraction, with possible mediation by Rho-kinase
(or a related kinase), although the endogenous generation of
SPC, associated with the Ca2-independent contraction of
vascular smooth muscle, will need to be demonstrated.
2. Materials and methods
2.1. Materials
Y-27632 was a gift from Yoshitomi Pharmaceutical Industries
(Osaka, Japan). Fura-2 AM (acetoxymethyl ester form of fura-2)
and ethyleneglycol-bis-(L-aminoethylether)-N,N,NP,NP-tetraacetic acid
(EGTA) were purchased from Dojindo Laboratories (Kumamoto,
Japan); sphingosine (SP), phosphorylcholine (PC), sphingomyelinase,
Triton X-100, PIPES, carbonyl cyanide 4-(tri£uoromethoxy) phenyl-
hydrazone (FCCP) and leupeptin were from Sigma (St. Louis, MO,
USA); SPC was from Sigma or Biomol (Plymouth Meeting, PA,
USA); L-escin was from Sigma or Katayama Chemical (Osaka, Ja-
pan); methanesulfonic acid, creatine phosphate disodium and hista-
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mine dihydrochloride were from Wako (Osaka, Japan); Staphylococ-
cus aureus K-toxin was from Research Biochemical International (Na-
tick, MA, USA); C2-ceraminde, sphingosine-1-phosphate (SPP) and
calmodulin were from Biomol; ATP and GTP were from Boehringer
Mannheim (Germany); ionomycin was from Calbiochem (Frankfurt,
Germany); and other reagents used were from Katayama Chemical.
SPC was at ¢rst dissolved in 100% ethanol and subsequently the
SPC/ethanol solution was dissolved in phosphate-bu¡ered solution
(PBS) containing 2 mg/ml bovine serum albumin to acquire a stock
solution (2 mM), as described [4]. The SPC stock solution was stored
at 380‡C.
2.2. Simultaneous measurements of tension and [Ca2+]i of arterial
smooth muscle
The left circum£ex coronary arteries (2^3 cm from the origin) of the
pig were cut into strips (1U4U0.1 mm) without endothelium and
adventitia and were loaded with [Ca2]i indicator dye, fura-2, as de-
scribed [15^17]. In brief, strips were incubated for 4 h at 37‡C in
normal physiological salt solution (normal PSS in mM: NaCl, 123;
KCl, 4.7; NaHCO3, 15.5; KH2PO4, 1.2; MgCl2, 1.2; CaCl2, 1.25;
and D-glucose, 11.5) gassed with a mixture of 5% CO2 and 95% O2
with the resulting pH of 7.4 and containing 12.5 WM fura-2 AM and
5% fetal bovine serum. The fura-2-loaded strips were mounted verti-
cally in a quartz organ bath and the tension was measured using a
force transducer (TB-612T, Nihon Koden, Japan). During 1 h of
incubation in normal PSS, for purposes of equilibration, the strips
were stimulated repeatedly with 118 mM K PSS every 15 min, and
the resting tension was adjusted to an optimal one (about 200 mg). To
assess the [Ca2]i levels, the ratio (F340/F380) of fura-2 £uorescence
intensities (at 500 nm) at alternating (400 Hz) excitation (340 and
380 nm) was monitored using a front-surface fura-2 £uorometer
(CAM-230, Japan Spectroscopic Co., Japan), as described [15^17]
but with a minor modi¢cation, in which randomly arranged optical
¢bers were used. In brief, strips were illuminated by guiding the ex-
citation light from a xenon light source through quartz optic ¢bers
randomly arranged in a circle (diameter 7 mm), and surface £uores-
cence of the strips was collected by glass optic ¢bers randomly ar-
ranged in the circle. Changes in tension and £uorescence ratio were
expressed as a percentage, assuming the values at a steady state in
normal (5.9 mM K) and 118 K mM PSS to be 0 and 100%, re-
spectively. The absolute values of [Ca2]i were determined in separate
measurements, with the use of the method and the following equation
described by Grynkiewicz et al. [18], with minor modi¢cations [15,19]:
Ca2i  KdR3Rmin=Rmax3RSf2=Sb2
where Kd is a dissociation constant and assumed to be 224 nM [18], R
is F340/F380, Rmax is obtained by the addition of 25 WM ionomycin in
the presence of extracellular Ca2 (1.25 mM Ca2) and Rmin is ob-
tained in the absence of extracellular Ca2 (0 mM Ca2 ; 2 mM
EGTA). Sf2/Sb2 is the ratio of proportionality coe⁄cients of free
dye and Ca2-bound dye at one wavelength (380 nM) and is under
the in£uence of various optical factors, including excitation intensity,
path length and instrumental e⁄ciency of collecting emitted photons
[18,19]. The mean values of [Ca2]i at normal PSS (at rest ; 0%) and
118 mM K-depolarization (100%) were 105.5 þ 3.8 nM (n = 10) and
718.2 þ 3.2 nM (n = 10), respectively. Because the calibration of
[Ca2]i was made on the assumption that the fura-2 signal was homo-
geneous despite a multicellular preparation, the Kd value of fura-2 in
the cytosol of vascular smooth muscle in the present experimental
condition was 224 nM (a Kd for fura-2 in the bu¡er with normal
ionic strength at pH 7.05 and 37‡C) and Sf2/Sb2 was 1; the [Ca2]i
values obtained were an approximation of the true [Ca2]i value [19].
2.3. Membrane permeabilization of arterial smooth muscle
Small strips (150^200 WmU2 mm) of the left circum£ex coronary
artery smooth muscle of the pig were dissected out [16,17]. Isometric
tension was measured using a force transducer (UL-2g, Minebea,
Japan) in a well on a ‘bubble’ plate at 28‡C [16,17,20,21]. The solution
was changed by sliding the bubble plate to an adjacent well. When
steady responses to high K were observed, the strips were incubated
for 10 min in normal relaxing solution (in mM: potassium methane-
sulfonate, 74.1; magnesium methanesulfonate, 2; MgATP, 4.5;
EGTA, 1; creatine phosphate, 10; PIPES, 30) containing 1 WM
FCCP as a mitochondria blocker and 1 WM leupeptin as a protease
inhibitor.
K-Toxin permeabilization of the coronary artery smooth muscle
strips was performed, as described [16,17]. In brief, the strips were
incubated with 0.12 mg/ml S. aureus K-toxin for 45^50 min in activat-
ing solution (pCa 6.3), in which 10 mM EGTA was used, a speci¢ed
amount of calcium methanesulfonate was added to give a desired
concentration of free calcium ions, and the ionic strength was kept
constant at 0.2 M by adjusting the concentration of potassium meth-
anesulfonate.
For L-escin and Triton X-100 permeabilizations, the strips were
incubated with 30 WM L-escin [20,21] and with 0.5% Triton X-100
[8], respectively, for 20^30 min in normal relaxing solution, as de-
scribed. Calmodulin (1 WM) was added to the activating solution
for L-escin- and Triton X-100-permeabilized strips.
The contractile e¡ect of SPC on the tension was examined at pCa
6.3. The tension levels were expressed as a percentage, assigning the
values in normal relaxing (pCaE8, nominally zero Ca2 with 10 mM
EGTA) and activating (pCa 4.5, bu¡ered with 10 mM EGTA) solu-
tions to be 0 and 100%, respectively. The value assigned to 100%
response (obtained with pCa 4.5) was observed before the start of
the experiments using K-toxin-permeabilized strips, and at the end
of the experiments in L-escin- and Triton X-100-permeabilized strips.
The values are expressed as the mean þ standard error. The Student’s
t-test was used to determine statistical signi¢cance, at P6 0.05.
3. Results
3.1. E¡ects of SPC on tension and [Ca2+]i of arterial smooth
muscle
SPC concentration-dependently (1^50 WM) induced sus-
tained contraction and slight [Ca2]i elevation in smooth
muscle of the porcine coronary artery (Fig. 1A,B). In Ca2-
free PSS containing 2 mM EGTA instead of 1.25 mM CaCl2
(complete removal of extracellular Ca2), SPC induced little
or no elevation of [Ca2]i (data not shown), suggesting that
SPC elevates [Ca2]i in vascular smooth muscle mainly by the
in£ux of extracellular Ca2, but not by the release of intra-
cellular Ca2. The extent of the contraction induced by 30 WM
SPC was much larger than that expected from the extent of
the [Ca2]i elevation, as compared with the contraction in-
duced by 118 mM K-depolarization (Fig. 1A). The SPC
e¡ect on the vascular smooth muscle is speci¢c, since SP
and PC (up to 100 WM) (Fig. 1C,D), both metabolites of
SPC, and 30 WM C2-ceramide (data not shown) had no ap-
parent e¡ect on the force. In addition, the contractile e¡ects
of 30 WM SPP and 0.1 U/ml sphingomyelinase were only
transient and much smaller (less than 20%) (data not shown)
than that for 30 WM SPC (61.2 þ 9.5%, n = 4) (Fig. 1A,B). The
speci¢city of the e¡ect of SPC over other sphingolipids is also
supported by the recent report that SPC selectively binds to
orphan receptor OGR1 with high a⁄nity and high speci¢city
[22].
3.2. E¡ects of SPC on the relationship between tension and
[Ca2+]i of arterial smooth muscle
To examine the relationship between tension and [Ca2]i,
we simultaneously observed changes in tension and [Ca2]i
when extracellular Ca2 was added in a cumulative manner
(from 0 to 1.25 mM) during 118 mM K-depolarization. The
cumulative addition of extracellular Ca2 induced a step-wise
increase in tension and [Ca2]i (Fig. 2A). As shown in Fig. 2B,
SPC concentration-dependently (1^50 WM) shifted the
[Ca2]i^tension curve to the left of the control curve obtained
with high K-depolarization. These results indicate that SPC
potentiates Ca2 sensitivity of the contractile apparatus of
vascular smooth muscle.
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3.3. E¡ect of SPC on the tension of permeabilized arterial
smooth muscle
To investigate the signal transduction pathway(s) involved
in the SPC-induced Ca2-sensitization of the contractile appa-
ratus, we used coronary arterial strips permeabilized with S.
aureus K-toxin. Since the permeabilization with K-toxin allows
molecules with a molecular mass of less than 1000 to pene-
trate the cell membrane [21,23], [Ca2]i can be controlled to a
constant value in case of use of a high bu¡er, 10 mM EGTA.
SPC (30 WM) enhanced (68.7 þ 2.9%, mean þ S.E., n = 4) the
contractile response to constant cytosolic Ca2 (pCa 6.3) bu¡-
ered with 10 mM EGTA (20.8 þ 1.1%, n = 4; P6 0.01) (Fig.
3A,B,D). This enhancement represents an increase in the Ca2
sensitivity of the contractile apparatus.
A G-protein-coupled receptor agonist, histamine (10 WM),
induced contraction at constant [Ca2]i (pCa 6.3) in the pres-
ence of 10 WM GTP but had little e¡ect in the absence of GTP
(Fig. 3A). In the same strip, 30 WM SPC induced Ca2-sensi-
tization at pCa 6.3, even in the absence of GTP (Fig. 3A).
These results are compatible with the involvement of the
G-protein-independent pathway in Ca2-sensitization induced
by SPC.
We reported that Rho-kinase induces smooth muscle con-
traction through an increase in the phosphorylation of myosin
light chain, independently of the Ca2-calmodulin-dependent
MLCK pathway [7,8]. Therefore, we examined the e¡ect of Y-
27632, a blocker of Rho-kinase [9], on the Ca2-sensitization
induced by SPC. The Ca2-sensitization induced by SPC was
partially inhibited by the subsequent addition of 10 WM
Y27632 (P6 0.05) (Fig. 3B,D). In contrast, the prior applica-
tion of 10 WM Y27632 abolished the SPC-induced Ca2-sensi-
tization (Fig. 3C,E). Y-27632 (up to 10 WM) itself had no
e¡ect on the contraction induced by pCa 6.3 (Fig. 3C,E),
such being compatible with a previous observation that 10
WM Y-27632 speci¢cally inhibits Rho-kinase, as compared
to MLCK [9]. Similar results were obtained using smooth
muscle strips permeabilized with L-escin (data not shown).
In L-escin-permeabilized strips, higher molecular weight com-
pounds (up to 150 kDa) can penetrate the membrane [21,24],
more so than in K-toxin-permeabilized strips (6 1 kDa)
[21,23], therefore Rho-kinase (s 150 kDa) should be retained
in the cytosol of the permeabilized strips [7]. In contrast,
30 WM SPC had no e¡ect on Triton X-100-permeabilized
smooth muscle (data not shown). We earlier observed that
most of the endogenous Rho-kinase in vascular smooth
muscle strips leaked out of the cells after Triton X-100-per-
meabilization [7,8]. Taken together, these results suggest the
involvement of Rho-kinase in the Ca2-sensitization induced
by SPC.
4. Discussion
The novel ¢nding of this study is that SPC induces not only
a slight elevation of [Ca2]i but also the potentiation of Ca2
sensitivity of the contractile apparatus, and induces smooth
muscle contraction. In addition, we also suggest that the SPC-
induced Ca2-sensitization was mediated by Rho-kinase (or a
related kinase sensitive to Y27632). These results were ob-
tained from experiments using a simultaneous measurement
of [Ca2]i and force in intact smooth muscle and a measure-
ment of Ca2-independent contraction in membrane-permea-
bilized smooth muscle.
We favor the view that SPC potentiates Ca2 sensitivity of
the contractile apparatus, for the following reasons: (1) SPC
increased the force/[Ca2]i ratio and shifted the curve of the
[Ca2]i^force relationship to the left in intact vascular smooth
muscle strips, as compared with the response to high K-
depolarization (Figs. 1 and 2) and (2) SPC induced contrac-
Fig. 1. E¡ects of SPC and its metabolites on [Ca2]i and tension in porcine coronary arterial strips. Resting levels and the plateau levels of the
contraction induced by 118 mM K were designated 0 and 100%, respectively. A: A representative recording showing the e¡ect of 30 WM SPC
on [Ca2]i and tension of the fura-2-loaded strips. B: Changes in [Ca2]i (open circle) and tension (closed circle) induced by various concentra-
tions (in abscissa) of SPC. Data represent the means (n = 4) of the values at 40 min after the application of SPC and are expressed as
mean þ S.E. C and D: Representative recordings showing the e¡ects of SP (C) and PC (D) on tension.
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tion at constant [Ca2]i in membrane-permeabilized strips
(Fig. 3). It was also observed that SPC reduces the Ca2
requirement for activating tissue transglutaminase [25].
The Rho-kinase inhibitor (10 WM Y-27632) abolished SPC-
induced Ca2-sensitization without a¡ecting the Ca2-induced
contraction (Fig. 3), which suggests involvement of Rho-ki-
nase in Ca2-sensitization induced by SPC. This notion is
supported by ¢ndings in the present study that SPC can in-
duce Ca2-sensitization in Rho-kinase-maintained vascular
strips permeabilized with K-toxin or with L-escin, but not in
the Triton X-100-permeabilized vascular strips in which Rho-
kinase had leaked out of the cells [7,8] (Fig. 3). The mecha-
nism(s) by which SPC activates Rho-kinase is unclear. Rho-
kinase has a pleckstrin homology domain, a lipid-binding
motif [13], which raises the possibility that some lipids may
directly a¡ect Rho-kinase and possibly regulate its kinase ac-
tivity. It was recently reported that puri¢ed Rho-kinase is
directly activated by arachidonic acid [13], a lipid messenger
which was found to induce Ca2-sensitization of permeabi-
lized smooth muscle [26]. This is also supported by the ¢nding
that the Ca2-sensitization induced by arachidonic acid was
blocked by a Rho-kinase blocker, Y-27632 [14]. Therefore,
one can hypothesize that SPC may also directly activate
Rho-kinase. However, post- rather than pre-incubation with
Y27632 more potently inhibited the arachidonic acid-induced
Ca2-sensitization [14], whereas in the present study we ob-
tained opposite results with the SPC-induced Ca2-sensitiza-
tion: the pre-incubation with Y27632 showed a more potent
inhibition of the SPC-induced Ca2-sensitization than did
post-incubation (Fig. 3). Therefore, even if SPC directly acti-
vates Rho-kinase, it is also likely that the activation mecha-
nism(s) of Rho-kinase may di¡er between SPC and arachi-
donic acid. In addition, arachidonic acid was reported to
induce the Ca2-sensitization through a variety of other ac-
tions [7], including the direct inhibition of myosin phospha-
tase activity [26] and the activation of atypical kinase C [27].
It was reported that SPP strongly activates G-protein-
coupled membrane receptors (EDG-1 and AGR16), which
are expressed in various types of cells, including vascular
smooth muscle cells [28,29]. It was also suggested that SPC
may elevate [Ca2]i perhaps through activation of these mem-
brane receptors [30,31], although SPC is a much less potent
agonist for the membrane receptors than is SPP [30,31]. In the
present study, we also found that SPC induced a slight ele-
vation of [Ca2]i in intact vascular smooth muscle strips (Fig.
1). It may be that SPC-induced [Ca2]i elevation is mediated
by the activation of membrane receptors. However, since exo-
genously applied SPC is rapidly taken up by intact cells [2,32],
the contractile e¡ect of SPC on the intact muscle may not
necessarily be mediated through the action of SPC on these
membrane receptors. Indeed, the contraction induced by SPC
is much larger than that of SPP (data not shown). Further-
more, the present study showed that SPC stimulated the in£ux
of extracellular Ca2, but not the release of intracellular Ca2,
whereas it has been well documented that activation of EDG-
1 and AGR16 stimulates both mechanisms of Ca2 mobiliza-
tion [30,31]. In contrast, our recent potency analysis of SPC
and SPP suggested no important role for these membrane
receptors in SPC-induced [Ca2]i elevation in endothelial cells
in situ, while SPC stimulates both Ca2 in£ux and Ca2 re-
lease [4]. In addition, Fig. 3A suggests the involvement of a G-
protein-independent pathway in Ca2-sensitization induced by
SPC, whereas sphingolipid receptors, EDG-1 and AGR16,
were reported to be coupled with G-protein. OGR1, expressed
in several tissues including small intestine [33] and for which
SPC was reported to be a high a⁄nity ligand, is also coupled
with G-protein and the potency of SPC for OGR1 (Kd = 33.3
nM) is far di¡erent from that in the present study [22]. There-
fore, it is likely that SPC may act intracellularly, but not
extracellularly (as agonist for these G-protein-coupled mem-
brane receptors). Therefore, we propose that SPC may be a
novel mediator for Ca2-sensitization of vascular smooth
muscle contraction, with possible mediation by Rho-kinase
(or a related kinase). On the other hand, it is also possible
that the contractile e¡ect of SPC may be mediated through
the action of SPC on unknown membrane receptors, which
are not coupled with G-protein and have a much lower a⁄n-
ity for SPC than currently known receptors, such as OGR1
and EDG. To con¢rm that SPC is a messenger in vascular
smooth muscle, it remains to be determined if sphingomyelin
generates SPC in vascular smooth muscle cells and what me-
tabolites are formed from SPC, using radiolabeling proce-
dures [34]; although 14C-labeled SPC was the only labeled
lipid detected by thin layer chromatography and there was
no signi¢cant labeling of lysoPC, PC or sphingomyelin, even
Fig. 2. A comparison of [Ca2]i^tension relationships of contrac-
tions induced by SPC and by 118 mM K. A: A representative re-
cording showing step-wise elevations of [Ca2]i and tension induced
by cumulative applications of extracellular Ca2 (0^1.25 mM) in the
presence of 118 mM K. B: The [Ca2]i^tension relationships of
the contractions obtained by the experimental protocol shown in
(A) (open circle, connected by a thin solid line) and of steady-state
contractions (at 40 min) induced by the various concentrations (1,
3, 10, 30 and 50 WM, as indicated by the number shown in the ¢g-
ure) of SPC (closed circle, connected by a thick solid line). The
data represent the means of four measurements with S.E.
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at 1 h after 14C-labeled SPC was applied to Swiss 3T3 ¢bro-
blasts [32].
SPC may play a role in disease states such as hypertension
and vasospasm. It was reported that Ca2-sensitization medi-
ated by Rho-kinase, which was suggested to be activated by
SPC in the present study (Fig. 3), is involved in the patho-
genesis of hypertension [9]. Y-27632, a speci¢c inhibitor of
Rho-kinase, controls hypertension in several hypertensive rat
models [9]. Since Ca2-sensitization by SPC was also abol-
ished by Y-27632, the biosynthesis of SPC in vascular smooth
muscle may be closely related to hypertension.
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